Background and Aims: There are few studies addressing the effect of weight loss on circulating levels of adipocytokines. The aim of our study was to determine whether different diets would have different weight loss effects and to examine the changes in adipocytokine levels. Methods: A population of 90 obesity non-diabetic outpatients was analyzed in a prospective way. The patients were randomly allocated to two groups: (a) diet I (low-fat diet), and (b) diet II (low-carbohydrate diet). At baseline and after 3 months on the diet, adipocytokines were evaluated. Results: 43 patients were randomized to group I and 47 patients to diet group II. No differences were detected between weight loss in either group (3.3 ± 0.51 vs. 4.4 ± 0.6 kg; n.s.). In group I, a significant decrease in leptin levels was found. In group II, leptin and C-reactive protein (CRP) levels also decreased. The decrease in leptin levels was lower with diet I than II (16.4 vs. 22.8%; p < 0.05). Conclusion: The serum leptin concentration decreased due to the 3-month intervention with low-fat and low-carbohydrate diets, without changes in other adipocytokines. The decrease in leptin and CRP levels were higher with a low-carbohydrate diet than a low-fat diet.

1.
Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban B; Grupo Colaborativo SEEDO: Prevalence of obesity in Spain. Med Clin (Barc) 2005;125:460–466.
2.
Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al: A low-carbohydrate as compared with a low diet in severe obesity. N Engl J Med 2003;348:2074–2081.
3.
Yancy WS, Olsen MK, Guytin JR, Bakst RP, Westman EC: A low carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 2004;140:140:769–777.
4.
Stern L, Iqbal N, Seshadri P, Thicano KL, Daily DA, McGrory J: The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow up of a randomized trial. Ann Intern Med 2004;140:778–785.
5.
Matsuda M, Shimomura I, Sata M: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487–37491.
6.
Kumada M, Kihara S, Sumitsuji S: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85–89.
7.
Shimomoura I, Hammer RE, Ikemoto S: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73–76.
8.
Steppan CM, Bailey ST, Bhat S: The hormone resistin links obesity to diabetes. Nature 2001;409:307–312.
9.
Matsuzawa Y: Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep 2005;7:58–62.
10.
Okasaki T, Himeno E, Nanri H, Ogata H, Ikeda M: Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol 1999;26:415–420.
11.
Xenachis C, Samojlik E, Raghuwanshi MP, Kirschner MA: Leptin, insulin and TNF-alpha in weight loss. J Endocrinol Invest 2001;24:865–870.
12.
Bastard JP, Jardel C, Bruckert E: Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338–3342.
13.
Hotta K, Funahashi T, Arita Y: Plasma concentrations of a novel, adipose specific protein, adiponectin in type 2 patients. Arterioscler Thromb Vasc 2000;20:1595–1561.
14.
Das SK, Roberts SB, Kehayiais JJ: Body composition assessment in obesity and after massive weight loss induced by gastric bypass surgery. Am J Physiol Endocrinol Metab 2003;284:E1080–E1088.
15.
Mataix J, Mañas M: Tablas de composición de alimentos españoles. Granada, University of Granada, 2003.
16.
Parker B, Noakes M, Luscombe N, Clifton P: Effect of a high-protein high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 2002;25:425–430.
17.
Piatti PM, Monti LD, Magni F, Fermo I, Baruffaldi L, Nasser R: Hypocaloric high protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high carbohydrate diet. Metabolism1994;43:1481–1487.
18.
Wadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB: Short- and long-term changes in serum leptin in dieting obese women: effects of caloric restriction and weight loss. J Clin Endocrinol Metab 1998;83:214–218.
19.
Wing RR, Sinha MK, Considine RV, Lang W, Caro JF: Relationship between weight loss, maintenance and changes in serum leptin levels. Horm Metab Res 1996;28:698–703.
20.
Considine RV, Sinha MK, Heimann ML: Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med 1996;334:292–295.
21.
Seshadri P, Samaha F, Stern L, Ahima R, Daily D: Adipocytokine changes caused by low carbohydrate compared to conventional diets in obesity. Metab Syndr Relat Disord 2005;3:66–74.
22.
Lazzer S, Vermorel M, Montaurier C, Meyer M, Boirie Y: Changes in adipocytokine hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents. Int J Obes 2005;29:1184–1189.
23.
Mavri A, Stegnar M, Sabovik M: Do baseline serum leptin levels predict weight regain after dieting in obese women? Diabetes Obes Metab 2001;3:293–296.
24.
Wallace AM, McMahon AD, Packard CJ, Kelly A: Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001;104:3052–3056.
25.
Seshari P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA: A randomized study comparing the effect of a low carbohydrate diet and a conventional diet on lipoprotein subfractions and C reactive protein levels in patients with severe obesity. Am J Med 2004;117:398–405.
26.
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29–33.
27.
Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29:1357–1361.
28.
Marfella R, Esposito K, Sinniscalchi N, Giugliano T: Effect of weight loss on cardiac synchronization and proinflammatory. Diabetes Res 2004;27:47:52
29.
Arvidsson E, Viguerie N, Andersson I, Verdich C, Langun D: Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004;53:1966–1972.
30.
Xydakis A, Case C, Jones P, Hoogeveen R, Liu M, Smith O: Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2005;89:2697–2703.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.